×

ENTER REPORT NAME TO SEARCH

Global PD-1/PD-L1 Inhibitors for Weight Loss Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301040013 | Category: Pharma & Healthcare | Pages: 107 | Format: PDF | Published Date: January 11,2023

Request Sample      Enquiry before buying    Ask For Discount   

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of PD-1/PD-L1 Inhibitors for Weight Loss
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 PD-1 Inhibitors
        1.3.3 PD-L1 Inhibitors
    1.4 Market Analysis by Application
        1.4.1 Overview: Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Woman
        1.4.3 Man
    1.5 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size & Forecast
        1.5.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity (2018-2029)
        1.5.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.1.4 Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Merck Recent Developments/Updates
    2.2 Bristol-Myers Squibb
        2.2.1 Bristol-Myers Squibb Details
        2.2.2 Bristol-Myers Squibb Major Business
        2.2.3 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.2.4 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bristol-Myers Squibb Recent Developments/Updates
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.3.4 Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Roche Recent Developments/Updates
    2.4 AstraZeneca
        2.4.1 AstraZeneca Details
        2.4.2 AstraZeneca Major Business
        2.4.3 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.4.4 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 AstraZeneca Recent Developments/Updates
    2.5 Ono Pharmaceutical
        2.5.1 Ono Pharmaceutical Details
        2.5.2 Ono Pharmaceutical Major Business
        2.5.3 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.5.4 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Ono Pharmaceutical Recent Developments/Updates
    2.6 Regeneron
        2.6.1 Regeneron Details
        2.6.2 Regeneron Major Business
        2.6.3 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.6.4 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Regeneron Recent Developments/Updates
    2.7 Innovent
        2.7.1 Innovent Details
        2.7.2 Innovent Major Business
        2.7.3 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.7.4 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Innovent Recent Developments/Updates
    2.8 Hengrui Medicine
        2.8.1 Hengrui Medicine Details
        2.8.2 Hengrui Medicine Major Business
        2.8.3 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.8.4 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Hengrui Medicine Recent Developments/Updates
    2.9 Junshi Biosciences
        2.9.1 Junshi Biosciences Details
        2.9.2 Junshi Biosciences Major Business
        2.9.3 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.9.4 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Junshi Biosciences Recent Developments/Updates
    2.10 Merck KGaA
        2.10.1 Merck KGaA Details
        2.10.2 Merck KGaA Major Business
        2.10.3 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Product and Services
        2.10.4 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Merck KGaA Recent Developments/Updates
3 Competitive Environment: PD-1/PD-L1 Inhibitors for Weight Loss by Manufacturer
    3.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Manufacturer (2018-2023)
    3.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Manufacturer (2018-2023)
    3.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of PD-1/PD-L1 Inhibitors for Weight Loss by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 PD-1/PD-L1 Inhibitors for Weight Loss Manufacturer Market Share in 2022
        3.4.2 Top 6 PD-1/PD-L1 Inhibitors for Weight Loss Manufacturer Market Share in 2022
    3.5 PD-1/PD-L1 Inhibitors for Weight Loss Market: Overall Company Footprint Analysis
        3.5.1 PD-1/PD-L1 Inhibitors for Weight Loss Market: Region Footprint
        3.5.2 PD-1/PD-L1 Inhibitors for Weight Loss Market: Company Product Type Footprint
        3.5.3 PD-1/PD-L1 Inhibitors for Weight Loss Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Region
        4.1.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Region (2018-2029)
        4.1.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Region (2018-2029)
        4.1.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price by Region (2018-2029)
    4.2 North America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value (2018-2029)
    4.3 Europe PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value (2018-2029)
    4.4 Asia-Pacific PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value (2018-2029)
    4.5 South America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value (2018-2029)
    4.6 Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Type (2018-2029)
    5.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Type (2018-2029)
    5.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Application (2018-2029)
    6.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Application (2018-2029)
    6.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price by Application (2018-2029)
7 North America
    7.1 North America PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Type (2018-2029)
    7.2 North America PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Application (2018-2029)
    7.3 North America PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country
        7.3.1 North America PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Country (2018-2029)
        7.3.2 North America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Type (2018-2029)
    8.2 Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Application (2018-2029)
    8.3 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country
        8.3.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Country (2018-2029)
        8.3.2 Europe PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Region
        9.3.1 Asia-Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Type (2018-2029)
    10.2 South America PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Application (2018-2029)
    10.3 South America PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country
        10.3.1 South America PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Country (2018-2029)
        10.3.2 South America PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country
        11.3.1 Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa PD-1/PD-L1 Inhibitors for Weight Loss Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 PD-1/PD-L1 Inhibitors for Weight Loss Market Drivers
    12.2 PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
    12.3 PD-1/PD-L1 Inhibitors for Weight Loss Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of PD-1/PD-L1 Inhibitors for Weight Loss and Key Manufacturers
    13.2 Manufacturing Costs Percentage of PD-1/PD-L1 Inhibitors for Weight Loss
    13.3 PD-1/PD-L1 Inhibitors for Weight Loss Production Process
    13.4 PD-1/PD-L1 Inhibitors for Weight Loss Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 PD-1/PD-L1 Inhibitors for Weight Loss Typical Distributors
    14.3 PD-1/PD-L1 Inhibitors for Weight Loss Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

It contains all the geographic trends, and market analysis for global market